National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Late Effects of Treatment for Childhood Cancer (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 04/24/2009
Table 16. Female Gonadal Late Effectsa

Late Effects  Causative Treatment  Signs and Symptoms  Screening and Diagnostic Tests  Management and Intervention 
aAdapted from Schwartz et al.[37]
Ovarian failure Chemotherapy: Mechlorethamine, cyclophosphamide, procarbazine, busulfan, melphalan, dacarbazine (DTIC), carmustine (BCNU), CCNU, ifosfamide Delayed/ arrested/ absent pubertal development including: breasts, female escutcheon, female habitus, vaginal estrogen effect, development of body odor and acne, changes in duration, frequency, and character of menses (cramping), estrogen deficiency: hot flashes, vaginal dryness, dyspareunia, low libido, infertility Tanner stage, LH, FSH, estradiol: (1) age 12 yrs, (2) failure of pubertal development, (3) baseline when fully mature, (4) as needed for symptoms, assess basal body temperature (midcycle elevation suggests ovulation), (dehydroepiandrosterone for failure of development) Hormone replacement (estrogen), anticipatory guidance regarding symptoms of estrogen deficiency and early menopause, referral to reproductive endocrinology, alternate strategies for parenting, early intervention (hormone replacement may prevent osteoporosis, atherosclerosis)
Radiation: 4–12 Gy tolerance decreases with increasing age
Surgery: Oophorectomy or oophoropexy
Vagina: fibrosis/diminished growth Chemotherapy: Actinomycin D and doxorubicin enhance radiation therapy effect) Dyspareunia, vaginal bleeding, small vaginal vault Pelvic exam (possibly under anesthesia) baseline, during puberty and as needed for symptoms Dilations, reconstructive surgery, potential need for cesarean section
Radiation: >40 Gy
Uterus: fibrosis/decreased growth Radiation: >20 Gy (prepubertal), >40–50 Gy (postpubertal) Multiple spontaneous abortions, low birth-weight infants, small uterus Pelvic: baseline, puberty, then annually Questionable endometrial biopsy, counsel regarding pregnancy
Ureter: fibrosis Radiation: >50–60 Gy Frequent UTIs, pelvic hypoplasia, hydronephrosis Urinalysis every year (urethrogram) UTI prophylaxis
Urethra: strictures Radiation: >50 Gy Frequent UTIs, dysuria, stream abnormalities Urinalysis every year, (voiding cystogram) UTI prophylaxis, surgical intervention
Surgery: Genitourinary

References

  1. Schwartz C L, Hobbie WL, Constine LS, et al., eds.: Survivors of Childhood Cancer: Assessment and Management. St. Louis, Mo: Mosby, 1994. 


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov